All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network.
The MPN Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the MPN Hub cannot guarantee the accuracy of translated content. The MPN Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
During the last steering committee (SC) meeting that was held on April 20, 2022, the SC members discussed about the future of JAK inhibition in myelofibrosis. The session was chaired by John Mascarenhas and involved an analysis from Claire Harrison, Haifa Kathrin Al-Ali, Tiziano Barbui, Jean-Jacques Kiladjian, and Stefan N. Constantinescu.
The future of JAK inhibition in myelofibrosis
Key topics of discussion included: “How to select appropriate JAK inhibitors in patients with myelofibrosis (MF)”; “What patient subsets a JAK inhibitor may capture”; and “The future of JAK inhibitors in treating myelofibrosis, and whether this type of inhibitor will exist as a single agent or in combination therapy at initiation.
Your opinion matters
New agents in the MF therapeutic landscape
During the MPN Hub Steering Committee meeting, we invited Steffen Koschmieder to give a presentation and chair a discussion on new agents in the MF therapeutic landscape.
Treatment sequencing in myelofibrosis
During the last steering committee (SC) meeting that was held on April 20, 2022, the SC members discussed about treatment sequencing in myelofibrosis. The session was chaired by Jean-Jacques Kiladjian and...
Subscribe to get the best content related to MPN delivered to your inbox